Document Detail

Leptin as a possible marker of augmented metabolic risk during pregnancy
MedLine Citation:
PMID:  16498365     Owner:  NLM     Status:  MEDLINE    
AIM: Leptin is a proteic hormone, isolated in 1994, mainly synthetized in the white adipose tissue. Aim of this study was to compare leptin concentrations in normal pregnancies with those measured in pregnancies complicated by gestational diabetes or gestational hypertension or pre-eclampsia. METHODS: We enrolled 48 pregnant women: 18 with uncomplicated pregnancy, 11 with gestational diabetes, 19 with gestational hypertension or pre-eclampsia. Leptin concentrations were measured in maternal serum at enrollment, together with insulin and cortisol, at delivery and in the immediate postpartum. At delivery serum leptin was calculated in the cord blood too. RESULTS: Fasting plasma leptin and insulin were higher in the group of patients with gestational hypertension, than in the other groups. Third-trimester maternal leptin concentrations correlated significantly with insulin levels in the group of women with gestational diabetes and in the group with gestational hypertension or pre-eclampsia, but not in the women with an uncomplicated pregnancy. CONCLUSIONS: Leptin concentrations in pregnancies complicated by hypertensive disorders are significantly higher than in normal pregnancies. The increased leptin concentrations are independent of associated proteinuria, as women with simple gestational hypertension and preeclampsia showed comparable third-trimester leptin concentrations. In both women with gestational diabetes and women with hypertensive disorders, serum leptin correlated closely with serum insulin, suggesting that the association between leptin and insulin resistance is preserved in pregnancy. Whatever the reasons for an increased maternal leptin production in pregnancies complicated by hypertension, maternal leptin homeostasis does not seem to influence foetal serum leptin concentrations, which seems to be mainly related to birth weight.
M Salvatores; G Gennarelli; G Menato; M Massobrio
Publication Detail:
Type:  English Abstract; Journal Article    
Journal Detail:
Title:  Minerva ginecologica     Volume:  58     ISSN:  0026-4784     ISO Abbreviation:  Minerva Ginecol     Publication Date:  2006 Feb 
Date Detail:
Created Date:  2006-02-24     Completed Date:  2006-07-05     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0400731     Medline TA:  Minerva Ginecol     Country:  Italy    
Other Details:
Languages:  ita     Pagination:  1-10     Citation Subset:  IM    
Dipartimento di Ginecologiche ed Ostetriche, Università degli studi di Torino, Turin.
Vernacular Title:
La leptina come possibile marker di aumentato rischio metabolico in gravidanza.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Biological Markers / blood
Diabetes, Gestational / blood*,  epidemiology
Hypertension, Pregnancy-Induced / blood*,  epidemiology
Leptin / blood*
Risk Factors
Reg. No./Substance:
0/Biological Markers; 0/Leptin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Aromatase enzyme and Alzheimer's disease.
Next Document:  The management of severe vaginal obstruction from genital chronic graft-versus-host disease: diagnos...